Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children

Haematologica. 2002 Jan;87(1):105-6.

Authors

Marta González-Vicent¹, Luis Madero, Julián Sevilla, Miguel Angel Díaz

Affiliation

¹ Department of Pediatrics, Division of Pediatric Hematology-Oncology, Niño Jesús Children's Hospital, Menéndez Palayo 65, 28009 Madrid, Spain.

PMID: 11801471

No abstract available

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use
Child
Child, Preschool
Cost-Benefit Analysis
Drug Costs
Female
Granulocyte Colony-Stimulating Factor / therapeutic use*
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Transplantation / economics*
Hospital Costs
Humans
Infant
Infection Control / economics
Leukocyte Count
Life Tables
Male
Neoplasms / therapy
Neutropenia / prevention & control
Neutrophils / immunology
Platelet Transfusion / economics
Transplantation, Autologous / economics
Treatment Outcome

Substances

Anti-Bacterial Agents
Granulocyte Colony-Stimulating Factor